Genesee Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Genesee Capital Advisors's ABBV Position: Q3 2026 in Review
Genesee Capital Advisors reduced its AbbVie (ABBV) stake by 0.54% in Q3 2026, selling an estimated $6.66K and leaving 4,818 shares worth $1.26M. The position accounts for 0.4% of the portfolio, ranked #55.
Genesee Capital Advisors first reported a position in ABBV in Q2 2020 and has held it in 22 quarters since. 4,280 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Genesee Capital Advisors held 4,818 shares of AbbVie worth $1.26M as of Q3 2026.
- Genesee Capital Advisors sold 26 AbbVie shares in Q3 2026, an estimated $6.66K.
- AbbVie made up 0.4% of Genesee Capital Advisors's portfolio in Q3 2026, its #55 holding.
- Genesee Capital Advisors first reported a position in AbbVie in Q2 2020 and has held it in 22 quarters since.
- 4,280 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Genesee Capital Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.